We found that inducing CAV1 expression in both TKI-naïve and TKI-resistant HCC cells altered levels of E-cadherin, p21 and RAC1/P70S6K/STAT3 pathway, promoting survival, invasiveness and chemoresistance. Here, CAV1 is linked to hepatocellular carcinoma.